Evidence map›Paper›PMID 35536645›Full record

ArticleThe Journal of clinical investigation2022

Caffeine intake exerts dual genome-wide effects on hippocampal metabolism and learning-dependent transcription.

Isabel Paiva, Lucrezia Cellai, Céline Meriaux, Lauranne Poncelet, Ouada Nebie, Jean-Michel Saliou, Anne-Sophie Lacoste, Anthony Papegaey, Hervé Drobecq, Stéphanie Le Gras and 24 more

Abstract read
In one paragraph

Article in The Journal of clinical investigation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Caffeine-mediated CD39Frontiers in immunology · 2026
    Article
  5. Article
  6. Upregulation of adenosine AMolecular psychiatry · 2025
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Adenosine and adenosine receptors in metabolic imbalance-related neurological issues.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2024
    Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors.

Isabel PaivaUniversity of Strasbourg, CNRS, UMR7364 - Laboratoire de Neurosciences Cognitives et Adaptatives (LNCA), Strasbourg, France.
Lucrezia CellaiUniversity of Lille, Inserm, CHU Lille, UMR-S1172 Lille Neuroscience & Cognition (LilNCog), Lille, France.
Céline MeriauxUniversity of Lille, Inserm, CHU Lille, UMR-S1172 Lille Neuroscience & Cognition (LilNCog), Lille, France.
Lauranne PonceletImaBiotech SAS, Parc Eurasanté, Loos, France.
Ouada NebieUniversity of Lille, Inserm, CHU Lille, UMR-S1172 Lille Neuroscience & Cognition (LilNCog), Lille, France.
Jean-Michel SaliouUniversity of Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UAR CNRS 2014 - US Inserm 41 - PLBS, Lille, France.
Anne-Sophie LacosteUniversity of Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UAR CNRS 2014 - US Inserm 41 - PLBS, Lille, France.
Anthony PapegaeyUniversity of Lille, Inserm, CHU Lille, UMR-S1172 Lille Neuroscience & Cognition (LilNCog), Lille, France.
Hervé DrobecqCentre d'Infection et d'Immunité de Lille (CIIL) - INSERM U1019 - UMR 9017, Lille, France.
Stéphanie Le GrasUniversity of Strasbourg, CNRS UMR7104, Inserm U1258 - GenomEast Platform - Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Illkirch, France.
Marion SchneiderPharmaCenter Bonn, Pharmaceutical Institute, Pharmaceutical and Medicinal Chemistry, University of Bonn, Bonn, Germany.
Enas M MalikPharmaCenter Bonn, Pharmaceutical Institute, Pharmaceutical and Medicinal Chemistry, University of Bonn, Bonn, Germany.
Christa E MüllerPharmaCenter Bonn, Pharmaceutical Institute, Pharmaceutical and Medicinal Chemistry, University of Bonn, Bonn, Germany.
Emilie FaivreUniversity of Lille, Inserm, CHU Lille, UMR-S1172 Lille Neuroscience & Cognition (LilNCog), Lille, France.
Kevin CarvalhoUniversity of Lille, Inserm, CHU Lille, UMR-S1172 Lille Neuroscience & Cognition (LilNCog), Lille, France.
Victoria Gomez-MurciaUniversity of Lille, Inserm, CHU Lille, UMR-S1172 Lille Neuroscience & Cognition (LilNCog), Lille, France.
Didier VieauUniversity of Lille, Inserm, CHU Lille, UMR-S1172 Lille Neuroscience & Cognition (LilNCog), Lille, France.
Bryan ThirouxUniversity of Lille, Inserm, CHU Lille, UMR-S1172 Lille Neuroscience & Cognition (LilNCog), Lille, France.
Sabiha EddarkaouiUniversity of Lille, Inserm, CHU Lille, UMR-S1172 Lille Neuroscience & Cognition (LilNCog), Lille, France.
Thibaud LebouvierUniversity of Lille, Inserm, CHU Lille, UMR-S1172 Lille Neuroscience & Cognition (LilNCog), Lille, France.
Estelle SchuellerUniversity of Strasbourg, CNRS, UMR7364 - Laboratoire de Neurosciences Cognitives et Adaptatives (LNCA), Strasbourg, France.
Laura TzeplaeffUniversity of Strasbourg, CNRS, UMR7364 - Laboratoire de Neurosciences Cognitives et Adaptatives (LNCA), Strasbourg, France.
Iris GrgurinaUniversity of Strasbourg, CNRS, UMR7364 - Laboratoire de Neurosciences Cognitives et Adaptatives (LNCA), Strasbourg, France.
Jonathan SeguinUniversity of Strasbourg, CNRS, UMR7364 - Laboratoire de Neurosciences Cognitives et Adaptatives (LNCA), Strasbourg, France.
Jonathan StauberImaBiotech SAS, Parc Eurasanté, Loos, France.
Luisa V LopesInstituto de Medicina Molecular, Faculdade de Medicina de Lisboa, Universidade de Lisboa, Lisbon, Portugal.
Luc BuéeUniversity of Lille, Inserm, CHU Lille, UMR-S1172 Lille Neuroscience & Cognition (LilNCog), Lille, France.
Valérie Buée-ScherrerUniversity of Lille, Inserm, CHU Lille, UMR-S1172 Lille Neuroscience & Cognition (LilNCog), Lille, France.
Rodrigo A CunhaCenter for Neuroscience and Cell Biology (CNC) and.
Rima Ait-BelkacemImaBiotech SAS, Parc Eurasanté, Loos, France.
Nicolas SergeantUniversity of Lille, Inserm, CHU Lille, UMR-S1172 Lille Neuroscience & Cognition (LilNCog), Lille, France.
Jean-Sébastien AnnicotteUniversity of Lille, INSERM, CNRS, CHU Lille, Institut Pasteur de Lille, Inserm U1283/CNRS UMR8199 - EGID, Lille, France.
Anne-Laurence BoutillierUniversity of Strasbourg, CNRS, UMR7364 - Laboratoire de Neurosciences Cognitives et Adaptatives (LNCA), Strasbourg, France.
David BlumUniversity of Lille, Inserm, CHU Lille, UMR-S1172 Lille Neuroscience & Cognition (LilNCog), Lille, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Caffeine is the most widely consumed psychoactive substance in the world. Strikingly, the molecular pathways engaged by its regular consumption remain unclear. We herein addressed the mechanisms associated with habitual (chronic) caffeine consumption in the mouse hippocampus using untargeted orthogonal omics techniques. Our results revealed that chronic caffeine exerts concerted pleiotropic effects in the hippocampus at the epigenomic, proteomic, and metabolomic levels. Caffeine lowered metabolism-related processes (e.g., at the level of metabolomics and gene expression) in bulk tissue, while it induced neuron-specific epigenetic changes at synaptic transmission/plasticity-related genes and increased experience-driven transcriptional activity. Altogether, these findings suggest that regular caffeine intake improves the signal-to-noise ratio during information encoding, in part through fine-tuning of metabolic genes, while boosting the salience of information processing during learning in neuronal circuits.

Indexed as

CaffeineProteomicsAnimalsHippocampusLearningMiceNeuronal PlasticityCaffeineEpigeneticsMemoryNeurosciencePharmacology

Identifiers

PMID35536645
PMCPMC9197525

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.